Related Experiment Video

Updated: Sep 6, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.7K

Statins and prostate cancer-hype or hope? The biological perspective

Joseph Longo1,2, Stephen J Freedland3,4, Linda Z Penn5,6

  • 1Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

Prostate Cancer and Prostatic Diseases
|June 29, 2022
PubMed

Insights

Statins may reduce advanced prostate cancer (PCa) risk and improve outcomes by inhibiting the mevalonate pathway. This review explores targeting this pathway for PCa treatment.

Area of Science:

  • Oncology
  • Metabolic pathways
  • Pharmacology

Background:

  • Growing evidence links statin use for cholesterol control to reduced advanced prostate cancer (PCa) risk and better outcomes.
  • The precise anti-neoplastic mechanisms of statins in PCa are not fully understood but are likely complex.
  • Statins are known inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), a key enzyme in the mevalonate (MVA) pathway.

Purpose of the Study:

  • To review observational and experimental data on statins as anti-cancer agents in prostate cancer.
  • To elucidate the role of deregulated mevalonate metabolism in prostate cancer progression.
  • To summarize the biological rationale for targeting the mevalonate pathway in prostate cancer treatment.

Main Methods:

  • Review of existing observational studies on statin use and prostate cancer.
  • Analysis of experimental data investigating statin mechanisms in prostate cancer.
  • Literature review on the mevalonate pathway's role in cancer progression.

Main Results:

  • Statins, by inhibiting HMGCR, impact the mevalonate pathway, which is implicated in prostate cancer progression.
  • Evidence suggests a link between statin therapy and reduced risk of advanced prostate cancer.
  • The mevalonate pathway presents a potential therapeutic target for prostate cancer.

Conclusions:

  • Targeting the mevalonate pathway, potentially with statins, offers a promising strategy for prostate cancer treatment.
  • Further research is warranted to fully understand and leverage the anti-cancer effects of statins in prostate cancer.
  • Understanding deregulated MVA metabolism is crucial for developing novel prostate cancer therapies.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

10.9K
An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.3K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
857
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
664
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
31
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K